In Vivo pan CAR therapy utilizing circular RNA for treatment of multiple myeloma
Rebecca Silver(Forma Therapeutics (United States)), Isin Dalkilic-Liddle(Forma Therapeutics (United States)), Oba Oseghali(Forma Therapeutics (United States)), Jeffrey W. Schindler(Forma Therapeutics (United States)), Jui Dutta-Simmons, Joe Bolen(Forma Therapeutics (United States)), Muthusamy Jayaraman(Forma Therapeutics (United States)), Kiran Madugula(Forma Therapeutics (United States)), Nandesh Mohan P(Forma Therapeutics (United States)), Megan D. Hoban(Fate Therapeutics (United States)), Rajat Das(University of Pennsylvania), Dong Wei(Forma Therapeutics (United States)), Maja Sedic(Forma Therapeutics (United States)), Karolina Kosakowska(Forma Therapeutics (United States)), Frank Neumann(Forma Therapeutics (United States))
Cited by 6
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
|Nature Biotechnology|2008|1.2k